Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice

Brain Research

Volumn 771, Issue 2, 1997, Pages 343-346

  Bhargava, Hemendra N ^a   Cao, Ying Jun ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antinociception; Morphine; Mouse; Noribogaine; Tolerance

Indexed keywords

IBOGAINE; MORPHINE; NORIBOGAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; IMMUNOLOGICAL TOLERANCE; IMPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; IBOGAINE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MORPHINE; PAIN MEASUREMENT; RECEPTORS, OPIOID;

EID: 0030785413     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00914-1     Document Type: Article

References (19)

1. Bhargava H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmacol. Rev. 46:1994;293-324.
2. Bhargava H.N. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a κ-opiate receptor agonist in the rat. Gen. Pharmacol. 26:1995;1055-1060.
3. Bhargava H.N., Cao Y.J., Zhao G.M. Effects of ibogaine and noribogaine on the antinociceptive action of μ-, δ-, and κ-opioid receptor agonists in mice. Brain Res. 752:1997;230-234.
4. Bhargava H.N., Matwyshyn G.A. Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology. 47:1993;344-350.
5. Cao Y.J., Bhargava H.N. Effects of ibogaine on the development of tolerance to the antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice. Brain Res. 752:1997;250-254.
6. Cappendijk S.L.T., Fekkes D., Dzoljic M.R. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine. Behav. Brain Res. 65:1994;117-119.
7. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
8. Deecher D.C., Teitler M., Soderlund D.M., Boenmann W.G., Kuekne M.E., Glick S.D. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res. 571:1992;242-247.
9. Dzoljic E.D., Kaplan C.D., Dzoljic M.R. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats. Arch. Int. Pharmacodyn. 294:1988;64-70.
10. Frances B., Gout R., Cros J., Zajac J.M. Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice. Fundam. Clin. Pharmacol. 6:1992;327-332.
11. Glick S.D., Rossman K., Rao N.C., Maisonneuve I.M., Carlson J.N. Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor. Neuropharmacology. 31:1992;497-500.
12. Glick S.D., Rossman K., Steindorf S., Maisonneuve I.M., Carlson J.M. Effects and after-effects of ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195:1991;341-345.
13. H. Lotsof, Rapid method for interrupting the narcotic addition syndromes, U.S. Patent 4,499,096 (1985).
14. Mash D.C., Staley J.K., Pablo J.P., Holohean A.M., Hackman J.C., Davidoff R.A. Properties of ibogaine and its principal metabolite (12-hydroxyibogaine) at the MK-801 binding sites of the NMDA receptor complex. Neurosci. Lett. 192:1995;53-56.
15. Pearl S.M., Davis K.H., Teitler M., Glick S.D. Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Res. 675:1995;342-344.
16. 3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology. 114:1994;672-674.
17. Popik P., Layer R.T., Fossom L.H., Benveniste M., Geter-Douglass B., Witkin J.M., Skolnick P. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. J. Pharmacol. Exp. Ther. 275:1995;753-760.
18. Sharpe L.G., Jaffee J.H. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat. NeuroReport. 1:1990;17-19.
19. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.